QUEST DIAGNOSTICS INC 8-K

What Happened

• Quest Diagnostics Incorporated announced on May 6, 2026 that it issued $500,000,000 aggregate principal amount of 5.000% senior notes due June 30, 2036. Interest is payable semiannually on June 30 and December 30, beginning December 30, 2026. The notes were issued under the company’s existing indenture with The Bank of New York Mellon as trustee and are senior unsecured obligations ranking equally with the company’s other senior unsecured debt. A legal opinion from Allen & Overy Shearman Sterling US LLP was filed with the 8-K.

Key Details

• Principal: $500,000,000; Coupon: 5.000% annually; Maturity: June 30, 2036.
• Interest payment dates: June 30 and December 30, beginning December 30, 2026.
• Status: Senior unsecured, no sinking fund, ranks pari passu with other senior unsecured obligations.
• Indenture protections: customary covenants limiting certain liens, sale-leaseback transactions and certain consolidations/asset transfers; change-of-control repurchase requirement at 101% of principal plus accrued interest.

Why It Matters

• This filing documents a material debt issuance that increases Quest Diagnostics’ long-term debt by $500 million and will add fixed interest expense at 5.000% annually.
• The notes are unsecured and rank equally with other senior unsecured debt, so they affect the company’s capital structure and creditor ranking but are not backed by specific assets.
• The covenant and change-of-control provisions provide customary protections for noteholders; investors should monitor overall leverage, interest coverage, and any company disclosures about the use of proceeds or changes to credit metrics.